Sarepta, battling slowing sales, claims Duchenne gene therapy’s impact grows with time
Sarepta, battling slowing sales, claims Duchenne gene therapy’s impact grows with time
本文は利用できません。元の情報源をご確認ください。
Sarepta, battling slowing sales, claims Duchenne gene therapy’s impact grows with time
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.